## Anti-CCP Antibody in Rheumatoid Arthritis **Key Point:** Anti-CCP (anti-cyclic citrullinated peptide) antibodies are the most specific autoantibodies for RA, with specificity >95%. They appear early in disease and predict progression to clinical RA in seronegative individuals. ### Pathophysiology of Anti-CCP Antibodies 1. **Citrullination Process** - Peptidylarginine deiminase (PAD) enzymes convert arginine residues to citrulline in joint proteins (fibrin, vimentin, collagen) - Citrullination occurs in response to inflammation, smoking, and infection - Creates neo-antigens that break B-cell and T-cell tolerance 2. **B-Cell Response** - Anti-CCP IgG antibodies form immune complexes - Activate complement via Fc receptors - Promote osteoclastogenesis and bone erosion ### Clinical Significance | Feature | Anti-CCP | Rheumatoid Factor (RF) | |---------|----------|----------------------| | Specificity for RA | >95% | 80–85% | | Sensitivity | 70–80% | 70–80% | | Appears in disease | Early (preclinical) | Later (clinical onset) | | Predicts erosions | Yes, strongly | Moderate | | Extra-articular disease | Yes, associated | Yes, associated | | Seronegative RA | Positive in 25–30% | Negative | **High-Yield:** Anti-CCP positivity in seronegative (RF-negative) patients still indicates high risk for erosive disease and warrants aggressive DMARD therapy. Anti-CCP status is more predictive of structural damage than RF alone. **Mnemonic:** **CCP = Cartilage Destruction Predictor** — Anti-CCP is the best predictor of radiographic progression and bone erosion in RA. **Clinical Pearl:** A patient with early inflammatory arthritis who is anti-CCP positive but RF negative has RA and requires DMARDs; RF seropositivity alone is less specific (can occur in other autoimmune diseases, infections, and even healthy individuals).
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.